This patent is useful for entities seeking to extract additional CD34 stem cells from placenta than can be normally gathered by just letting the blood drip and collecting cord blood. This patent has one independent claim that covers, essentially perfusing the placenta with an anticoagulated solution after the cord blood has dripped out.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.